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ABSTRACT: Possible predictors of reported lower cognitive functioning in irradiated children with acute lymphoblastic leukemia (ALL) were investigated. Thirty-four subjects, 5-14 years old, with ALL in continuous complete
remission and without evidence of current or past central nervous system disease, were examined 9-11 O months
after diagnosis, using standard measures of intelligence and academic achievement. Subjects with a history
of post-irradiation somnolence syndrome were significantly older at diagnosis than nonsomnolent subjects.
Intelligence (IQ) was found to be unrelated to history of somnolence syndrome. IQ and achievement were unrelated
to age at irradiation, irradiation-examination interval, and radiation dosages. The strongest predictor ot IQ by
far is parental social class. The importance of controlling for social class differences when searching for treatment effects on IQ and achievement is stressed. J Dev Behav Pediatr 9:122-128, 1988. Index terms: lymphoblastic
leukemia, cranial irradiation, somnolence syndrome, intelligence, achievement.

Prophylactic cranial irradiation and improved
chemotherapy have greatly decreased the incidence of central nervous system (CNS) leukemia and increased survival
rates in children with acute lymphoblastic leukemia (ALL)
in the last 15 years. 1 Interest has shifted to the quality of
psychological survival in these children, and particularly to
effects of CNS irradiation on intelligence (IQ) and achievement. This paper examines factors that might be expected to
contribute to present or future intellectual difficulties in
ALL patients. Four have been suggested:
I. Post-irradiation somnolence syndrome. Ch'ien et al2
reported seizures and "learning difficulties," definep as

"dull normal intelligence, short attention span and poor
recent memory," in children who had a history of somnolence syndrome, but not in children without such a
history. This syndrome is characterized by drowsiness
and lethargy occurring 3-8 weeks after the end of cranial
irradiation3 and was first observed by Druckmann4 in
children receiving low dose cranial irradiation for tinea
capitis.
2. Age at irradiation. The younger, incompletely myelinated brain may be more vulnerable to irradiation. 5
Three reports have demonstrated a relationship between
young age at irradiation and low IQ; 6 · 8 four have failed
to demonstrate a significant relationship. 9 - 12
3. IrradiatiOn-examination interval. fotellectual pertormance has been reported to be significantly diminished 3
years, but not I year, after irradiation. 13-is In contrast, no
significant correlation between long irradiationexamination interval and IQ was found by Robinson et
al12 in which the mean interval was 7.2 years.
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4. Radiation dosage. Supposing that radiation damages
the brain, it is logical to hypothesize poorer outcome in
patients receiving more radiation. No correlation between radiation dosage and measures of IQ, visualmotor integration, attention, concentration, or shortterm memory has been found in two previous studies.10. 16
The present study was undertaken to examine the effects
of somnolence syndrome, age at irradiation, irradiationexamination interval, and radiation dosage on IQ and academic achievement of children with leukemia in continuous, complete remission. This study differs from
previously published reports in that (a) it includes a total
patient population selected only for age at examination, (b)
the same measures are used in all subjects, (c) it excludes
subjects with other possible causes of low IQ, and (d) it
statistically controls for social class differences.

METHODS
Sample
The subjects of this study included every patient with
acute lymphoblastic leukemia (ALL) who was (1) between
the ages of 5 and 14, (2) without evidence at any time of central nervous system (CNS) or systemic relapse of leukemia,
and (3) without history of CNS disease (including encephalitis, meningitis, and seizui:e disorders), or Down syndrome. Of 43 children meeting the first two criteria, four
were excluded because of central nervous system (CNS)
disease or Down syndrome leaving 39 who met all three
criteria (including one child who had a single febrile seizure
in infancy, years prior to diagnosis). Thirty-three were fully
studied: one child, age 5, refused to talk but completed
nonverbal psychometric tests; four parents completed a
behavioral questionnaire (not reported on here) only; and
one family refused to participate at all. Twelve of the 39
subjects were still receiving chemotherapy at the time of
examination. All subjects attended the Pediatric
Hematology-Oncology Clinic in the Babies Hospital of the
Presbyterian Hospital in the City of New York, or an affiliated hospital. Subjects were treated with Children's
Cancer Study Group Protocols 101, 141, 14la, 161, 162,
163, or 905. 11 - 23 Subjects were 14-139 months old at
diagnosis (mean 60.1, median 55.5) and were examined
9-110 months (mean 49.0, median 45.0) later. All had been
irradiated (1800 or 2400 rads) within 2 months of diagnosis.
Therefore, in this report, "time since diagnosis" and "time
since irradiation" are virtually equivalent. A minimum interval of 6 months between diagnosis and examination was
chosen on the assumption that most children will have
recovered from the acute illness and returned to school by
that time.
Measures
1. Psychometric testing. Subjects were tested by experienced psychometricians who knew that the children were
in continuous complete remission but were blind to the
hypotheses of the study and to history of somnolence,
age at irradiation, and radiation dosage. An ageappropriate Wechsler intelligence test (WISC-R, 24 or
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WPPSl25) and the reading comprehension, spelling, and
mathematics subtests of the Peabody Individual
Achievement Test26 were administered.
2. Social class. The Hollingshead Four Factor Index of
parental education and employment was used to determine social class (social class: 1 =highest, 5 = lowest). 27
3. Assessment of somnolence. Each subject's chart was
searched for symptoms of somnolence syndrome 2•3 in
the notes that had been recorded at weekly to monthly
clinic visits during the 4 months after the start of cranial
irradiation. If the child was rehospitalized during this
period, daily progress and nursing notes were reviewed.
A diagnosis of somnolence syndrome was made if the
examining physician had specifically noted the presence
of the syndrome or if the words "drowsiness" or
"lethargy" or a synonym of these appeared in the record
during the third through eighth weeks after the end of
cranial irradiation. We excluded symptoms of somnolence occurring before the third week (three cases, of
which two occurred during the course of irradiation and
one after), as well as symptoms which could be attributed to other causes, e.g., intercurrent infection or
drug side effects. In no case did somnolence symptoms
begin after the eighth week, but in five cases, symptoms
persisted beyond the eighth week.

Procedure
Informed consent was obtained from a parent in the
presence of the child. Psychometric testing and other
measures (to be reported elsewhere) usually were completed
in a single morning or afternoon session. Children were not
tested on a day when lumbar puncture or bone marrow
examination was scheduled, and psychometric testing
usually preceded other measures.
Medical records were surveyed twice for symptoms of
somnolence syndrome and the abstracts were checked for
accuracy. Assignment to the somnolent or nonsomnolerit
groups was made from the abstracts independently by three
of us (PT, CE, AC) who were blind to the identity of the
subject and psychometric test results, but not to age at
diagnosis or radiation dosage. Where disagreement occurred (11 of 34 cases), we reviewed abstracts and medical
records together and reached a consensus, in every instance
rating doubtful cases as nonsomnolent. This procedure was
therefore weighted toward assigning nonsomnolent ratings.
Data Analysis
Histograms were plotted to assess the distribution of continuous variables, and scatterplots were inspected to
evaluate the possibility of nonlinear relationships between
variables. Z-tests for point estimates when population
means are known were used to determine deviance from
population norms. Chi-square tests were used for categorical data, two-tailed t-tests and Pearson productmoment correlations for continuous variables, and multiple
regression analyses were used to partial out the effects of
several different factors measured. In addition, in the regression of IQ on radiation dosage and age at irradiation,
we included as an independent variable an interaction term,
namely, the product of rads and age at irradiation.
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RESULTS
Inspection of the histograms demonstrated sufficient
variability and distributions appropriate to satisfy the
assumptions of normality for statistical procedures. Inspection of scatterplots of full scale, verbal, and performance
IQ (FSIQ, VIQ, PIQ) against the continuous variables of
socioeconomic status (SES), age at irradiation, and followup interval revealed only linear relationships between the
various dependent and independent variables.

Cognitive Functioning of the Entire Sample
This study was not designed and is not intended to assess
whether as a group, children with acute lymphoblastic
leukemia (ALL) exhibit cognitive deficits. However, it is of
some interest to compare the cognitive functioning of this
sample to available normative data. Mean FSIQ
(98.5 ± 19.2), VIQ (98.6 ± 20.1), and PIQ (98.9 ± 18.9) in
this sample were not significantly different than population
norms{µ= 100±15). Of the 10 subtests of the Wechsler
intelligence tests, only information (x = 8.6 ± 4.0) and
arithmetic (x =8.8 ± 3.0) were significantly different
(p < 0.01) from population norms (µ = 10 ± 3). There was
no difference between this sample and population norms
on reading achievement (x =99.9± 15.3; µ= 100± 15.3;
µ= 100 ± 15), but arithmetic (x =95.1±15.8) and spelling
(x = 94.2±15.9) achievement were both significantly lower.
Socioeconomic Status
The mean SES of the entire sample was 2.6 ± 1.3. Social
class was highly correlated with all three measures of IQ
(VIQ: r = - 0.67, p < 0.001; PIQ: r = - 0.31, p < 0.05;
FSIQ: r = - 0.60, p < 0.001).
Somnolence
Of the 39 subjects who met inclusion criteria, 18 (460Jo)
were rated somnolent. These subjects were significantly
older when irradiated than nonsomnolent subjects
[75.4 ± 33.8 vs 52.6 ± 25.3 months, t(37) = 2.41,p < 0.05]
but did not differ in age at examination (117. 7 ± 37.4
vs 105.1 ± 31.2 months), follow-up interval (42.9 ± 25.8 vs
TABLE 1. Somnolence, IQ, and School Achievement
Nonsomnolent
(n = 18)

VIQ•
PIO"
FSIQ"
PIAT reading
Comprehension°
Mathematics 0
Spelling 0
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Somnolent
(n = 16)

x

SD

x

SD

92.1b
98.7
94.5b

21.1
21.9
21.4

105.4
99.3
102.7

16.9
15.6
16.3

97.8d
91.1
92.2

17.2
17.5
15.6

102.3d
99.6
96.3

12.9
12.6
16.6

• WISC-R or WPPSI.
b n = 17.
c Age standard scores.
d n = 15.
All differences nonsignificant. Abbreviations: VIQ, verbal IQ; PIO, performance IQ; FSIQ, full-scale IQ; PIAT, Peabody Individual Achievement
Test.

52.4 ± 24.9 months), radiation dosage (2106 ± 305
vs 2187 ± 285 rads), or sex distribution (560Jo vs 520Jo male).
Although not statistically significant, there were more lower
social class subjects [Hollingshead class IV, V) in the nonsomnolent (6/18) than somnolent (3/16) groups [X2 (1
dD=0.33, p<0.54]. Three nonsomnolent and two somnolent subjects refused psychometric testing; subsequent
analyses are based on 34 subjects.
Table 1 shows a 13-point difference in VIQ between somnolent and nonsomnolent groups. This difference only approaches significance [!(31) = 2.00, p < 0.06], and is in the
opposite of predicted direction, the somnolent group
having a higher VIQ. Other IQ and achievement test differences are also nonsignificant.
If young age at irradiation predicts later cognitive problems, lower VIQ might have resulted from the younger age
at irradiation of nonsomnolent subjects. In an analysis of
covariance, controlling for age at irradiation, higher VIQ
remained nonsignificantly related to somnolence
(F1,29= 2.92, p < 0.10).

Age at Irradiation and Irradiation-Examination
(Follow-up) Interval
Because we chose to examine subjects at least 5 years old,
children who were older at diagnosis are likely to have
shorter follow-up intervals. Therefore, these two variables
are related to each other (r = 0.31,p < 0.05), but their independent contribution is considered here. The Pearson
product-moment correlations of IQ and age at irradiation
and follow-up interval are shown in Table 2. No significant
relationship was found. Achievement scores were not significantly correlated with age at irradiation or follow-up
interval.

Radiation Dosage
Radiation dosage was dichotomized (high = 2400 rads,
low= 1800 rads). Higher dosage was weakly (nonsignificantly) correlated (point biserial) with lower IQ scores
(Table 2), and was unrelated to achievement scores. We
TABLE 2. Pearson Correlations of IQ and Achievement with Age
at Irradiation, Follow-up Interval, and Radiation Dosage and Social
Class

n
VIQb
PIQb
FSIQb
PIAT reading
Comprehension•
Mathematics•
Spelling•

33

34
33
33
34

34

Age
Irradiation Follow-up• Rads

SES

0.174
0.125
0.188

- 0.246 - 0.225
-0.118 -0.181
-0.219 -0.189

- 0.672°
-0.319d
-0.6000

0.065
0.153
0.051

0.186 -0.138
0.070 -0.069
0.110 -0.165

-0.559°
-0.511 1
-0.544°

• Follow-up = age at examination minus age at irradiation.
b WISC-A or WPPSI.
c p < 0.001.
d p < 0.05.
• Age standard scores.
1
p < 0.01, all other correlations nonsignificant.
Abbreviations: SES, socioeconomic status; VIQ, verbal IQ; PIO, performance IQ; FSIQ, full-scale IQ; PIAT, Peabody Individual Achievement Test.
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found no interaction between radiation dosage and age at
irradiation.
Finally, to assess the relative importance of the various
factors that have been reported to contribute to lower IQ,
we conducted four two-variable stepwise regression analyses. In each regression equation, VIQ was first regressed on
SES, the variable with, by far, the strongest zero-order relation to IQ. SES accounted for 45% of the variance in VIQ
(Table 3). In step two, one of four variables (somnolence,
age at irradiation, follow-up interval, rads) was entered.
This method allows one to assess the relative importance of
each variable in predicting VIQ. None of the four step-two
variables accounted for significant additional variance in
VIQ after SES was entered. Somnolence approached significance but in the opposite of expected direction
(F1,30 = 3.93, p = 0.057). The four two-variable stepwise
regressions were repeated using PIQ and FSIQ as the outcome. Again, no significant additional variance was found.
TABLE 3. Two-step Regression: R2 Increase in IQ After Controlling
for SES
PIQ

VIQ

(n
Somnolence
Age at irradiation
Follow-up interval
Rads
R2 for SES alone

= 33)

0.064"
0.014
0.042
0.033
0.451b

(n

= 34)

FSIQ

(n

= 33)

0.001
0.024
0.024
0.003

0.019
0.019
0.034
0.016

o.153c

0.360b

•p = 0.057.
bp < 0.001.
c p < 0.05, all others nonsignificant.
Abbreviations: SES, socioeconomic status; VIQ, verbal IQ; PIO, performance IQ; FSIQ, full-scale IQ.

DISCUSSION

This study examined four factors which may contribute
to intellectual deficits in children treated for acute
lymphoblastic leukemia (ALL): somnolence syndrome,
age at irradiation, follow-up interval, and radiation
dosage. The subjects included a total clinic population of
irradiated ALL patients in continuous complete remission
who were 5-14 years old at the time of examination, excluding only those patients whose intellectual abilities
might have been lowered by factors other than those under
study, such as central nervous system (CNS) or systemic
relapse (with added chemotherapy and/or CNS irradiation), seizures, or Down syndrome. The same psychological measures were used on all subjects, and social class
was statistically controlled for. Only one 28 of the previously published studies examined the relative contribution of possibly deleterious factors (social class and age
at diagnosis) to outcome as this report does.
We could not confirm the direct relationship between
somnolence syndrome and "learning difficulties" as reported
by Ch'ien et al, 2 a finding also unconfirmed by other
studies. 29•30 Because our information on somnolence syndrome was derived from retrospective record review, it is
possible that some misclassification took place. However,
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our somnolence rate of 46% is similar to that reported in
nine other studies (overall mean for 698 subjects: 430/o,
range 10-780Jo )2•3•29-30 and to the 51 % rate reported for prospective studies only (range 36-660Jo). 2•29- 32•34 We might
expect that if misclassification was obscuring a real relationship between somnolence syndrome and intelligence (IQ),
than a comparison of cases with positive chart notation of
somnolence syndrome (n = 7) to cases free of somnolence
symptoms (n = 17) (thus excluding ambiguous cases) might
yield a significant difference. This analysis approaches statistical significance, but in the opposite of predicted direction.
Specifically, somnolent subjects had higher verbal IQ (VIQ)
(109.3 vs 92.1", t= 1.98,p<0.06) and were significantly older
(78. 7 vs 50.6 months, t = 2.2, p< 0.05) than nonsomnolent
subjects.
Neither did we find significant differences between
somnolent and nonsomnolent subjects on achievement
measures. A more recent report by Ch'ien's group, 29 with a
much larger sample size, shows similiar means and standard deviations and no significant differences between
somnolent and nonsomnolent groups. Perhaps the discrepancy between our results and those of Ch'ien et al,2 in
their original paper, can be accounted for by the latter's
inclusion of one subject who developed leukoencephalopathy after treatment with high dose intravenous
methotrexate and cranial irradiation (Ch'ien, 1980, personal communication).
We did not find lower IQ in subjects who were younger
at irradiation or had longer follow-up intervals. The
literature on these factors is far from consistent. Although
three of the better-controlled studies found lower IQ in
younger irradiated subjects, 6- 8 others have failed to
demonstrate a significant relationship. 9- 12 Reports oflower
IQ in longer irradiation-examination interval subjects12- 1s
are unreliable, in that follow-up interval and age at irradiation are confounded. None of these studies controls for
social class or age at irradiation differences. It is possible
that there are delayed effects on IQ which subside over
time. We found no obvious nonlinear pattern in the
scatterplot of IQ versus follow-up interval, but since this
study is not longitudinal, it is possible that the interindividual variations in IQ would obscure a pattern that
would emerge in longitudinal data.
We found a nonsignificant trend for higher radiation
dosage to be associated with lower IQ, but young age at
irradiation and high n~diation dosage do not appear to
interact. Examination of a larger sample of low- and highdose subjects would be valuable. If such a study substantiated an inverse relationship between radiation
dosage and IQ, a switch to lower radiation dosage treatment regimens would be indicated, since CNS prophylaxis
with 1800 rads has been shown to be as effective as with
2400 rads. 36
As noted above, this study was not designed to assess
whether treatment of ALL leads to cognitive deficits. To
study this issue, ideally one would need prediagnosis IQ
and achievement data. This is impractical, because it
would require testing an extremely large number of
children to obtain a cohort who eventually developed this
rare disorder. Postdiagnosis but pretreatment test results

126

TRAUTMAN ET AL

would not necessarily reflect the premorbid functioning of
these severely ill children. Premorbid school records
would be of interest, but would vary from school to
school. Further, many newly diagnosed children have not
yet attended school.
In the absence of premorbid data, an appropriate comparison group would allow assessment of the effect of
leukemia and its treatment on cognitive functioning. Unaffected siblings might serve as a control group for family
influences of heredity and environment. Children with
other forms of cancer who do not receive intrathecal
medication or cranial irradiation might serve as controls for
effects of illness and missed school. These control groups
have been utilized in other studies which were specifically
designed t9 assess whether there is a cognitive deficit caused
by this disease.
The currently available literature about the effects of
cranial irradiation on IQ is not consistent. Whereas a few
studies demonstrate lower IQ in irradiated leukemic
children than in nonirradiated controls,6· 7·16,37 a greater
number do not. 6·10·12 -13 •28 ·38 -44 (The negative studies are
generally, but not uniformly, less well-designed.) Some
studies that purport to show IQ differences include subjects
with CNS leukemia and systemic relapse,44- 45 or do not
clearly exclude subjects with other possible cause for low
IQ, such as seizures or encephalopathy.9.31
In the present study, no control group was utilized, since
it was designed to assess the effect of several treatment factors within a total patient population. Comparison of the
data from this sample to population norms should be interpreted with caution. Cognitive functioning in leukemia patients can be adversely affected by treatment and yet not fall
below normal range. If, for some reason, the patient population is biased toward higher premorbid levels of cognitive
functioning, even substantial declines from premorbid levels
could result in "normal" test scores. The present sample provides an example of such a possible bias. The mean social
class of this sample (2.6 ± 1.3) is significantly higher than
in the general population (µ=3.7±1.0, p<0.001). The
unstandardized regression coefficients from a regression
analysis of IQ on socioeconomic status (SES), age at irradiation, and somnolence indicate that in this sample, a decrease
of one level of SES leads to an 8. 7-point decrease in full scale
IQ (FSIQ) and a 10.0-point decrease in VIQ. As the sample
mean SES is approximately one level higher than the population mean, we might expect sample mean IQ to have been
higher than the population mean IQ at baseline. The fact
that, after treatment, the sample IQ mean is slightly lower
than population norms could represent a decline in.intellectual functioning. Without premorbid data or appropriate
age, SES, and treatment-matched controls, it is not possible
to say what overall effect, if any, treatment has had on these
subjects.
We found that our subjects scored significantly lower
than population norms on information and arithmetic subtests of the Wechsler scales and on Peabody arithmetic and
spelling achievement tests, but not reading comprehension.
The available literature shows no consistent pattern of deficiencies in Wechsler subtestsMo,41 or achievement tests
(three reported no differences from controls,38.4l,43 one
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reported lower WRAT arithmetic but not word recognition
or spelling,40 and one reported superior arithmetic achievement) in irradiated versus nonirradiated leukemic
subjects. 28 Again, our study was not designed to evaluate
this issue, and further research needs to be done on the pattern of deficits in these children.
We wish to emphasize the importance of controlling for
social class (as measured by parental education and occupation) in this research area. In our sample, children of
social classes 4 and 5 had significantly lower VIQ and FSIQ
than subjects in social classes 1, 2, and 3. Parental social
class is a good predictor of a child's IQ and achievement. 46
It is easy to see how nonrandom distribution of social class
can bias cognitive findings in a small sample. Most reports
do not control for social class;9•10- 14.16·30·38-45·47.48 only Moss
et al, 6 Eiser,7 Eiser and Lansdown, 8 Whitt et al, 28 and
Jannoun 37 do.
A methodological difficulty that affects the present study
is its small sample size. Since the sample represents a total
patient population in the given age range, biases present
should be limited to those introduced by the selection by
age. Although there are children in the sample who were
diagnosed and irradiated when as young as 14 months old,
there are no recently diagnosed children who are younger
than 5 years old. However, IQ assessment below the age of 5
is not reliable, and available instruments do not correlate
well with Wechsler scales. The sample is too small to explore
adequately the effecis that this age restriction introduces.
However, since there is a complete range of age at diagnosis
and irradiation, bias will hopefully be minimal and not
affect the interpretation and generalization of positive
findings.
More problematic is the interpretation of negative
findings. Lack of statistical significance at p = 0.05 level
does not prove the null hypothesis. The sample size in this
study provides us with a power of 0.80 to detect a 15-point
(one standard deviation) difference between group means in
IQ and achievement !-tests. However, smaller group differences of 10 or even 7.5 points could be clinically important. In this study, we only have power of 0.28 on t- tests
and 0.30 on regression analyses to detect differences between groups of 7 .5 IQ points. This is clearly inadequate. A
sample size of 126 subjects (63/group) would be required to
detect a 7 .5 IQ-point difference with a power of0.80. Such a
sample size will require a multicenter study.
In summary, our data support previously published reports that postirradiation somnolence syndrome does not
predict later cognitive dysfunction. Somnolence is more frequently observed in older children. The data do not support
young age at irradiation or longer diagnosis-examination
interval as predictors of cognitive dysfunction. The trend
toward lower IQ in children receiving higher radiation
dosages bears further investigation. Our data, which show
the powerful contribution of social class to cognitive outcome, cast doubt on other reports of irradiated leukemia
patients which fail to control for social class differences
among subjects and control groups. Despite the logistic difficulties inherent in such work, multicenter research is advocated to obtain sample sizes that provide adequate power to
detect important effects on IQ and academic achievement.

,
l

Prediction of Intellectual Deficits

Acknowledgment. This project was supported in part by grants
from the William T. Grant Foundation, NIMH 5T32 16434-01,
NIMH 5T01 MH 07715-19, and NIMH Mental Health Clinical
Research Center Grant MH 30906-0-5.
We thank the families who participated in this study, and Drs.
James Wolff, Michael Weiner, Steven Glaser, and Rao Vinnakota

127

for allowing us to study their patients; Sue Brinkworth, Ph.D., and
Carmen Rodriguez, Ph.D., for psychometric testing; Kevin
McDonagh for record reviews; Carlotta Harris, who helped with
many aspects of data collection; Mark Davies, M.P.H., for help
with data analysis, and Nora Miller, Maryjo D'Elia, and Penny
Cooper for secretarial assistance.

REFERENCES

1. Bleyer WA: Neurologic sequelae of methotrextrate and ionizing
·radiation: A new classification. Cancer Treat Rep 65 (suppl
10):89-98, 1981
2. Ch'ien L, Aur R, Stagner S, et al: Long-term neurological implications of somnolence syndrome in children with acute lymphocytic
leukemia. Ann Neurol 8:273-277, 1980
3. Freeman JE, Johnston PGB, Yoke JM: Somnolence after prophylactic cranial irradiation in children with ALL. Br Med J
4:523-525, 1973
4. Druckmann A: Schlafsucht als Folge der Rontgen bestralung.
Beitrag zur Strahlenenempfindlichkeit des Gehirns. Strahlentherapie 33:382-384, 1929
5. Davison AN, Peters A: Myelination. Springfield, IL, Charles C.
Thomas, 1970
6. Moss H, Nannis E, Poplack D: The effects of prophylactic treatment of the CNS on the intellectual functioning of children with
acute lymphocytic leukemia. Am J Med 71:47-52, 1981
7. Eiser C: Effects of chronic illness on intellectual development.
Arch Dis Child 55:766-770, 1980
8. Eiser C, Lansdown R: Retrospective study of intellectual development in children treated for acute lymphoblastic leukemia. Arch
Dis Child 52:525-529, 1977
9. Rowland JH, Glidewell OJ, Sibley RF, et al: Effects of different
forms of central nervous system prophylaxes on neuropsychological function in childhood leukemia. J Clin Oncol
12: 1327 -1335' 1984
10. Harten G, Stephani U, Henze G, et al: Slight impairment of
psychomotor skills in children after treatment of acute lymphoblastic leukemia. Eur J Pediatr 142:189-197, 1984
11. Pavlosky S, Castano J, Leiguarda R, et al: Neuropsychological
study in patients with ALL. Am J Pediatr Hematol Oncol 5:79-86,
1983
12. Robinson LL, Meadows AT, Nesbit ME, et al: Factors associated
with IQ scores in long-term survivors of childhood acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 6:115-121, 1984
13. Stebhens JA, Kisker Ct: Intelligence and achievement testing in
childhood cancer: Three years post-diagnosis. J Dev Behav Pediatr
5:184-188, 1984
14. Meadows AT, Gordon J, Massari DJ, et al: Declines in IQ scores
and cognitive dysfunctions in children with acute lymphocytic
leukemia treated with cranial irradiation. Lancet 2:1015-1018,
1981
15. Moehle KA, Berg RA: Academic achievement and intelligence test
performance in children with cancer at diagnosis and one year
later. J Dev Behav Pediatr 6:62-64, 1985
16. Tamaroff M, Salwen R, Miller DR, et al: Neuropsychologic sequelae in irradiated children with acute lymphoblastic leukemia
(ALL). Proc Am Soc Clin Oncol 4:165, 1985
17. Green OM, Freeman AI, Sather HN, et al: Comparison of three
methods of central-nervous-system prophylaxis in chfldhood acute
lymphoblastic leukemia. Lancet 1:1398-1401, 1980
18. Nesbit ME, Sather HN, Ortega JA, et al: Effect of isolated central
nervous system leukemia on bone marrow remission and survival
in childhood acute leukemia. Lancet 1:1386-1388, 1981
19. Miller DR, Leikin SL, Albo V, et al: Use of prognostic factors in
improving the design and efficiency of clinical trials in childhood
leukemia. Cancer Treat Rept 64:381-392, 1980
20. Leikin SL, Albo V, Lee S, et al: Reinduction and pulse therapy in
acute lymphocytic leukemia (ALL). Proc Am Assoc Cancer
Res -Am Soc Clin Oncol 22:486, 1981

21. Coccia PF, Bleyer WA, Siegel SE, et al: Reduced therapy for
children with good prognosis acute lymphoblastic leukemia
(ALL). Blood 58 (suppl 1):137a, 1981
22. Coccia PF, Bleyer WA, Siegel SE, et al: Development and
preliminary findings of Children's Cancer Study Group protocols
(CCG-161, 162, 163) for low, average, and high risk acutelymphoblastic leukemia in children, in Murphy S, Gilbert JR (eds):
Leukemia Research, Advances in Cell Biology and Research.
North Holland, Elsevier Publishing, 1983
23. Baum ES, Sather HN, Nachman J, et al: Relapse rates following
cessation of chemotherapy during complete remission of acute
lymphocytic leukemia. Med Pediatr Oncol 7:25-34, 1979
24. Wechsler D: The Wechsler Intelligence Scale for Children-Revised.
New York, The Psychological Corporation, 1974
25. Wechsler D: The Wechsler Pre-School and Primary Scale of Intelligence (WPPSI). New York, The Psychological Corporation,
1967
26. Dunn LM, Markwardt FC: Peabody Individual Achievement Test.
Circle Pines, MN, American Guidance Service, Inc, 1975
27. Hollingshead AB: Four Factor Index of Social Status. New Haven,
CT, Yale University, 1975
28. Whitt JK, Wells RJ, Lauria MM, et al: Cranial radiation in
childhood acute lymphocytic leukemia: Neuropsychologic sequelae. Am J Dis Child 138:730-736, 1984
29. Berg A, Ch'ien LT, Lancaster W, et al: Neuropsychological sequlae of postradiation somnolence syndrome. J Dev Behav Pediatr
4:103-107, 1983
30. Inati A, Sallen SE, Cassady JR, et al: Efficacy and morbidity of CNS
"prophylaxis" in childhood ALL: Eight years' experience with cranial
irradiation and intrathecal methotrexate. Blood 61:297-303, 1983
31. Garwicz S, Aronson AS, Elmquist D, et al: Post-irradiation syndrome
and EEG findings in children with ALL. Acta Paediatr Scand
64:399-403, 1975
32. Versosa MS, Aur RJA, Simone JV, et al: Five years after central
nervous system irradiation of children with leukemia. Int J Radiat Oncol Biol Phys 2:209-215, 1976
33. Littman P, Rosenstock J, Gale G, et al: The somnolence syndrome in
leukemic children following reduced daily dose fractions of cranial
radiation. Int J Radiat Oncol Biol Phys 10:1851-1853, 1984
34. Parker D, Malpas JS, Sandland R, et al: Outlook following 'somnolence syndrome' after prophylactic cranial irradiation. Br Med J
1:554-559, 1978
35. Hustu HO, Aur RJA, Verzosa MS, et al: Prevention of CNS leukemia
by irradiation. Cancer 32:585-597, 1973
36. Nesbitt ME, Sather HN, Robinson LL, et al: Presymptomatic central
nervous system therapy in previously untreated childhood acute
lymphoblastic leukemia: Comparison of 1800 rad and 2400 rad.
Lancet 1:461-466, 1981
37. Jannoun L: Are cognitive and educational development affected by
age at which prophylactic therapy is given in acute lymphoblastic
leukemia? Arch Dis Child 58:953-958, 1983
38. Soni S, Marte G, Pitner S, et al: Effects of CNS irradiation on neuropsychologic functioning of children with acute lymphocytic leukemia.
N Engl J Med 292:113-118, 1975
39. Obetz S, Smithson W, Groover R, et al: Neuropsychological follow-up
study of children with acute lymphocytic leukemia. Am J Pediatr
Hematol Oncol 1:207-213, 1979
40. Ivnik RJ, Colligan RC, Obetz SW, et al: Neuropsychological performance among children in remission from acute lymphocytic
leukemia. J Dev Behav Pediatr 2:29-34, 1981

128

TRAUTMAN ET AL

41. Baron IS, Gluck RS, Brallier D, et al: Long-term neuropsychological
effects of central nervous system prophylaxis in acute Jymphocytic
leukemia. Paper presented at the 9th annual meeting of the International Neuropsychological Society, Atlanta, GA, Feb 7, 1981
42. Stebhens JA, Ford ME, Kisker CT, et al: WISC-R verbal/performance discrepancies in pediatric cancer patients. J Pediatr Psychol
6:61-68, 1981
43. Lansky SB, Cairns OF, Cairns NU, et al: Central nervous system prophylaxis. Studies showing impairment in verbal skills and academic
achievement. Am J Dis Child 138:730-736, 1984
44. Goff J, Anderson JR, Cooper MS: Distractibility and memory deficits
in long-term survivors of acute lymphoblastic leukemia. J Dev Behav
Pediatr 1:158-163, 1980

JDBP/June, Vol. 9, No. 3

45. Pfefferbaum-Levine B, Reid HL, Copeland DR, et al: Neuropsychologic assessment of long-term survivors of childhood leukemia.
Am J Pediatr Hematol Oncol 6:123-128, 1984
46. Scare S, Carter-Saltzman L: Genetics and intelligence, in Sternberg RJ
(ed): Handbook of Human Intelligence. Cambridge, Cambridge
University Press, 1982, pp 792-896
47. Moss HA, Nannis Ed: Psychological effects of central nervous system
treatment of children with acute lymphocytic leukemia, in Kellerman J
(ed): Psychological Aspects of Childhood Cancer. Springfield, IL,
Charles C. Thomas, 1980, pp 171-183
48. Eiser C: Intellectual abilities among survivors of childhood leukemia as
a function of CNS irradiation. Arch Dis Child 53:391-395, 1978

